Trial Profile
Multicenter, Randomised, Double Blind Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications Marfan syndrome
- Focus Therapeutic Use
- Acronyms MARFAN-SARTAN; MARFANSARTAN
- 13 Jun 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Jul 2012 New trial record